IDRA Past Earnings image   This IDRA past earnings page last updated 1/20/2023
IDRA Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/14/2022-1.020
Q2 20228/9/2022-1.700
Q1 20225/5/2022-1.360
Q4 20213/31/2022-1.360
Q3 202111/8/2021-1.870
Q2 20218/9/2021-2.210
Q1 20214/29/2021-4.080
Q4 20203/1/2021-3.740
Q3 202010/29/2020-3.570
Q2 20208/4/2020-4.080
Q1 20204/30/20203.740
Q4 20193/12/2020-6.800
Q3 201911/6/2019-6.630
Q2 20198/8/2019-6.630
Q1 20195/2/2019-6.630
Q4 20183/6/2019-7.650
Q3 201811/6/2018-7.310
Q2 20188/2/2018-10.030
Q1 20185/9/2018-13.600
Q4 20173/7/2018-10.880
Q3 201711/6/2017-13.600
Q2 20178/7/2017-19.040
Q1 20175/4/2017-13.600
Q4 20163/15/20171.360
Q3 201610/28/2016-13.600
Q2 20168/2/2016-14.960
Q1 20165/9/2016-14.960
Q4 20153/10/2016-13.600
Q3 201511/6/2015-13.600
Q2 20158/6/2015-14.960
Q1 20155/11/2015-16.320
Q4 20143/12/2015-19.040
Q3 201411/7/2014-14.960
Q2 20148/12/2014-13.600
Q1 20145/13/2014-16.320
Q4 20133/13/2014-13.600
Q3 201311/14/2013-14.960
Q2 20138/15/2013-20.400
Q1 20135/15/2013-20.400
Q4 20123/11/2013-32.640
Q3 201211/12/2012-23.120
Q2 20128/9/2012-20.400
IDRA Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/14/20220.05M
Q2 20228/9/2022NA
Q1 20225/5/2022NA
Q4 20213/31/2022NA
Q3 202111/8/2021NA
Q2 20218/9/2021NA
Q1 20214/29/2021NA
Q4 20203/1/2021NA
Q3 202010/29/2020NA
Q2 20208/4/2020NA
Q1 20204/30/2020NA
Q4 20193/12/2020NA
Q3 201911/6/2019NA
Q2 20198/8/20190.00B
Q1 20195/2/2019NA
Q4 20183/6/201999000
Q3 201811/6/2018145000
Q2 20188/2/2018163000
Q1 20185/9/2018255000
Q4 20173/7/2018173000
Q3 201711/6/2017164000
Q2 20178/7/2017187000
Q1 20175/4/2017378000
Q4 20163/15/201715.28M
Q3 201610/28/2016323000
Q2 20168/2/2016301000
Q1 20165/9/2016294000
Q4 20153/10/2016190000
Q3 201511/6/201520000
Q2 20158/6/20155000
Q1 20155/11/201534000
Q4 20143/12/20152000
Q3 201411/7/201430000
Q2 20148/12/201438000
Q1 20145/13/20143000
Q4 20133/13/20140.00M
Q3 201311/14/20130.01M
Q2 20138/15/20130.03M
Q1 20135/15/20130.01M
Q4 20123/11/20130.01M
Q3 201211/12/20120.00M
Q2 20128/9/20120.03M
Quotes delayed 20 minutes

Email EnvelopeFree IDRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Idera Pharmaceuticals (IDRA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

IDXX Past Earnings
IDYA Past Earnings
IGMS Past Earnings
IIN Past Earnings
IKNA Past Earnings
IKT Past Earnings
ILMN Past Earnings
IMAC Past Earnings
IMGN Past Earnings
IMGO Past Earnings

IDRA Past Earnings Q&A

What was the best and worst IDRA past earnings results?
For Idera Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest IDRA past earnings result in our data set was 3.740/share posted in Q1 2020, while the lowest was in Q4 2012 when IDRA posted -32.640/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2016 when IDRA reported 15.28M in revenue, while the quarter with the lowest revenue in our data set was Q2 2022 at NA of revenue.

  Suggested answer: There are 42 IDRA past earnings results in our data set.

On this page we presented the IDRA past earnings date information for Idera Pharmaceuticals. Reviewing that IDRA Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2020, when IDRA posted gaap of 3.740/share. Meanwhile the lowest IDRA past earnings result was in Q4 2012, when IDRA posted gaap of -32.640/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2016 when IDRA reported 15.28M in revenue, while the smallest revenue quarter was Q2 2022 when IDRA reported NA in revenue.

Any self directed investor doing their due diligence on IDRA or any other given stock can benefit from researching all of the Idera Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Idera Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for IDRA. Thanks for visiting, and the next time you need to research IDRA past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: WFT Price Target, CPK YTD Return, OII Price Target.


IDRA Past Earnings | | Copyright © 2020 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.